NF-kB is an inducible transcription factor, which is regulated by interaction with inhibitory IkB proteins. Previous studies linked the activity of NF-kB to the proliferative state of the cell. Here we have analysed the function of NF-kB in the cell cycle. Inhibition of NF-kB in HeLa cells by stable overexpression of a transdominant negative IkB-a protein reduced cell growth. A kinetic analysis of the cell cycle revealed a retarded G1/S transition. The IkB-a overexpressing cell clones showed a decreased percentage of cells in the S phase and an impaired incorporation of bromodeoxyuridine (BrdU). The amounts of cyclins A, B1, D1, D3, and E were unchanged, but the G1-speci®c proteins cyclin D2 and cdk2 were strongly elevated in the IkB-a overexpressing cell clones. These cell clones also displayed an increase in cyclin D1-dependent kinase activity, pointing to a cell cycle arrest at the late G1 phase. IkB-a overexpression crosstalked to cell cycle checkpoints via a reduction of transcription factor p53 and elevation of p21 WAF . Surprisingly, the IkB-a overexpressing cells showed an enrichment of c-Myc in the nucleoli, although the total amount of c-Myc protein was unchanged. These experiments identify an important contribution of the NF-kB/IkB system for the growth of HeLa cells.
Introduction
In mammals the inducible transcription factor NF-kB can be composed of ®ve dierent DNA-binding subunits including c-Rel, v-Rel, RelA (p65), RelB, NF-kB1 (p50/p105), and NF-kB2 (p52/p100) (for review see Finco and Baldwin, 1995; Baeuerle and Baltimore, 1996; Siebenlist, 1997; May and Ghosh, 1998) . These transcription factors share an N-terminal homology domain, which mediates DNA-binding, dimerization, nuclear translocation and interaction with regulatory proteins including the inhibitory IkB proteins (Chen et al., 1998 ; for review see IsraeÈ l, 1995; Scheidereit, 1996) . The IkB proteins comprise a gene family of at least eight members that all contain socalled ankyrin repeats. In most cell types NF-kB, which is typically a heterodimer of the p50 and the p65 (RelA) subunits, is sequestered in the cytoplasm by the binding to one IkB protein. Constitutive NF-kB activity can only be detected in certain cell types including cells from the monocyte/macrophage lineage, mature B-cells, T-cells and some types of neurons (for review see Baldwin, 1996 ; O'Neill and . A wide variety of stimuli including tumor necrosis factor a (TNF-a), interleukin-1 (IL-1), lipopolysaccharide (LPS), phorbol-12-myristate 13-acetate (PMA) and more general stimuli such as UV radiation and oxidative stress lead to the induced phosphorylation of the two major forms of IkB proteins, termed IkB-a and IkB-b. The inducible phosphorylation at serines 32 and 36 signals for the subsequent ubiquitinylation and degradation by the 26 S subunit of the proteasome (for review see Baldwin, 1996; Verma and Stevenson, 1997) . The inducible phosphorylation of IkB-a is mediated by kinases puri®ed in high molecular weight complexes (Chen et al., 1996) . Two of these IkB-a kinases (IKK-a and IKK-b) were recently cloned by several laboratories (DiDonato et al., 1997; Mercurio et al., 1997; Regnier et al., 1997; Woronicz et al., 1997; Zandi et al., 1997) . The mutation of serines 32 and 36 results in an increased half life of IkB-a and suppresses NF-kBdependent transcription more eciently than the wildtype form of IkB-a (Brockman et al., 1995; Brown et al., 1995; Traenckner et al., 1995) . Induced degradation of IkB proteins unmasks the nuclear localization sequences of the DNA-binding subunits and allows NF-kB to enter the nucleus, bind to its cognate DNA sequence and induce transcription of its target genes.
Many of the target genes play an important role in various aspects of the immune response as well as the promotion or inhibition of apoptosis (for review see Baichwal and . NF-kB is also involved in the regulation of cell growth. The ®rst report on the involvement of NF-kB in the cell cycle came from the observation that NF-kB was activated during the G0/ G1 transition in mouse ®broblasts (Baldwin et al., 1991) . NF-kB is induced by many mitogenic stimuli and the addition of serum to G0-arrested 3T3 cells results in the activation of NF-kB (Duckett et al., 1995) . Furthermore, activation of this transcription factor can be seen during the onset of regenerative and proliferative processes, for example at the start of liver regeneration after hepatectomy (FitzGerald et al., 1995) . Accordingly, the stimulation of smooth muscle cells with growth factors such as PDGF-BB, bFGF, EGF and IGF-1 leads to the rapid activation of NFkB, but growth inhibitors such as IFN-g failed to do so (Obata et al., 1996) . The transformation of cells by Bcr-Abl, a chimeric oncoprotein, required the activation of NF-kB (Reuther et al., 1998) . The inhibition of the p65 subunit of NF-kB by antisense RNA or trapping the DNA-binding subunits of NF-kB in a transcription factor decoy approach impairs the growth of several cell lines (Higgins et al., 1993; Sharma et al., 1996) . Similarly, the induced expression of c-Rel arrests the proliferation of HeLa cells (Bash et al., 1997) .
In this study we inhibited the transcription factor NF-kB by overexpressing a transdominant negative form of IkB-a. We show that NF-kB contributes to cell growth and the kinetics of G1/S-transition. The abundance or localization of the cell cycle checkpoint regulators p53, p21
WAF and c-Myc was directly or indirectly in¯uenced.
Results
In contrast to gene disruption experiments that target individual genes, the inhibition of NF-kB by overexpression of a transdominant negative form of IkB-a allows the simultaneous inhibition of several members of this transcription factor family by preventing the DNA-binding activity of the transactivating subunits c-Rel and p65. Therefore this experimental approach allows the detection of phenotypes that are invisible in gene disruption experiments (Bushdid et al., 1998; Kanegae et al., 1998) . Other DNA-binding subunits such as the RelB/p52 heterodimer and RelB/p50 dimers are not high anity targets for the IkB-a subunit (Dobrzanski et al., 1994) . The analysis of NFkB in the cell cycle was so far not easy to address, since targeted deletion of the p65 subunit leads to premature death of 14-days-old embryos . In order to study the eects of NF-kB on parameters of cell growth and cell cycle we have chosen to inhibit this transcription factor by stable overexpression of a transdominant negative IkB-a mutant, in which the serines 32 and 36 were changed to alanines. This mutation prevents the inducible phosphorylation and confers an increased half-life to the protein (for review see Stancovski and Baltimore, 1997) .
Overexpression of IkB-a impairs growth of HeLa cells
We stably introduced a vector encoding the mutant IkB-a protein or the empty expression vector RcCMV as a control into HeLa cells. Thirty days after addition of the selection marker G418, the cell clones were isolated and expanded in conditioned medium. At this stage it already became obvious that the various clones displayed heterogeneous growth rates. Sixteen of the clones were growing extremely slow and died approximately 1 ± 2 weeks after picking. Eighteen surviving clones grew also signi®cantly slower than a pool of HeLa cells stably transfected with the control vector RcCMV (HeLa wt cells). The relative levels of IkB-a protein were compared between the surviving clones and HeLa wt cells in Western blot experiments ( Figure 1a) . Some of the dierent clones showed higher expression levels of IkB-a than HeLa wt cells. The Western blot displayed in Figure 1a identi®ed elevated IkB-a protein levels in the clones number 5, 7 and 9. In all of our experiments we identi®ed a total of 28 cell clones with high levels of IkB-a (data not shown).
The induced DNA-binding activity of these clones was compared to HeLa wt cells in EMSAs. Treatment of cells with the phorbol ester PMA readily induced the DNA-binding form of NF-kB in HeLa wildtype cells. The IkB-a overexpressing clones 5 and 7, in contrast, displayed a signi®cantly decreased DNAbinding activity after stimulation with PMA ( Figure  1b) . As exempli®ed by the comparison of clones 5 and 7, these EMSAs revealed a correlation between the relative expression levels of IkB-a and the reduction of NF-kB DNA-binding. A similarly decreased DNAbinding was seen for the majority of the IkB-a overexpressing clones (data not shown). The four clones that showed the weakest DNA-binding capacity (numbers 7, 12, 14 and 19) were chosen for the further analysis. Subsequently the subcellular localization of the transactivating p65 subunit was investigated under various conditions using an immunocytochemical approach. A monoclonal antibody against an epitope on the transactivating p65 subunit of NF-kB which selectively stains the activated form of NF-kB (Kaltschmidt et al., 1995) detected weak immunoreactivity in the cytoplasm and a residual activity in the nucleus of HeLa wt cells. Already 20 min after the addition of PMA, most of the p65 protein was found in the nucleus (Figure 2a upper) . The IkB-a overexpressing HeLa cells, in contrast, were unable to translocate the p65 subunit to the nucleus after exposure of cells either PMA or TNF-a (Figure 2b upper). These results show, that the overexpression of the transdominant negative form of IkB-a inhibits the DNA-binding of NF-kB by preventing the nuclear entry of the DNA-binding subunits.
The IkB-a overexpressing clones also showed striking changes of the cell shape and displayed ā attened morphology. They were more extended and branched than their wildtype counterparts, that had the rhombic appearance typical for HeLa cells ( Figure  2c ). The altered shape of the IkB-a overexpressing clones is presumably due to the impaired expression of structural proteins. All 18 clones that displayed impaired cell growth showed high levels of IkB-a and strongly decreased activation of NF-kB (Table 1) . This strict correlation show that an impairment in NF-kB activation is accompanied by decreased growth rates. IkB-a expression and NF-kB activation could not be tested in the extremely growth retarded cell clones, but all of them displayed the¯attened morphology typical for IkB-a expressing clones (data not shown).
The slower growth rate of some of the clones was directly quanti®ed. Equal numbers of cells from various clones were grown at identical conditions and the number of cells was determined at various time points (Figure 3a ). This analysis revealed an approximately three times longer doubling time for the various IkB-a overexpressing clones in comparison to the HeLa wt cells. The growth rates of the individual cell clones also displayed some heterogeneity ( Figure 3a ).
IkB-a overexpressing HeLa cells show a retarded G1/S transition
The cell cycle was investigated by comparing the DNA contents of the wildtype and IkB-a overexpressing HeLa cells in a¯ow cytometer. The DNA content of the HeLa wt cells showed a cell cycle distribution typical for exponentially growing cells. The IkB-a overexpressing HeLa cells, in contrast, showed a decreased percentage of cells in the S phase and an increased percentage of cells in the G1 phase. The proportion of tetraploid cells in G2/M phase was essentially unchanged, but the shape of the G2/M peak was frequently found to be¯atter (Figure 3b ). The reduced S phase in the IkB-a overexpressing HeLa cells was further characterized by measuring the BrdU incorporation in exponentially growing HeLa wt and IkB-a overexpressing cells. The BrdU incorporation was determined by immuno¯uorescence ( Figure 3c ). All tested IkB-a overexpressing cell clones showed a signi®cantly decreased incorporation of BrdU. The impaired BrdU incorporation displayed some variation between the dierent IkB-a overexpressing clones and was maximal in clone 7 with only 50% of the BrdU incorporation seen in the HeLa wt cells. These data con®rm the ®nding of a decreased S phase obtained by the analysis of the cellular DNA content.
To determine kinetic parameters of the cell cycle, the DNA content was analysed after arresting the cells at the late G2 stage by addition of 1 mM vinblastine. Eighteen hours after the addition of vinblastine a signi®cant percentage of HeLa wt cells had left the G1 and S phase and was arrested at G2 (Figure 4a ). At this time most of the IkB-a overexpressing cells remained almost entirely in the G1 or S phase, as exempli®ed here for clone 7. Thirty-six hours after the addition of vinblastine the majority of HeLa wt cells were in the G2 phase, whereas a substantial proportion of IkB-a overexpressing clones were still in the G1 phase. These data are indicative for a retarded exit from G1, but do not show whether the cells stay at the G1 or G2/M phase.
To investigate a possible impact on G1/S transition, the expression and localization of known regulators of the G1/S checkpoint was investigated. Total cell extracts prepared from HeLa wt and IkB-a overexpressing HeLa cells were tested by Western blot analysis for cyclin-dependent kinase (Cdk) 2 and various cyclins, which serve as regulatory subunits for Cdks. No signi®cant dierences in the expression of cyclins A (which is typically expressed during the S and G2 phase of the cell cycle), B1, and D3 were found (Figure 4b ). However, the G1 marker proteins cyclin D2 and cdk2 were contained in signi®cantly higher amounts in the IkB-a overexpressing cell clones (Figure 4b ), indicating an impaired G1/S transition in the IkB-a overexpressing cells.
We next compared the activities of the cyclin D1-and cyclin E-associated kinases. Exponentially growing HeLa wt and IkB-a overexpressing cells were lysed. Equal amounts of protein were immunoprecipitated with anti-cyclin E or with anti-cyclin D1 antibodies. The activity of cyclin-associated kinases was tested in vitro by using either histone H1 (for cyclin E-associated kinases) or the C-terminal part of the Rb protein (for cyclin D1-associated kinases) as a substrate ( Figure  5a ). The relative expression of the cyclin D1 and cyclin E proteins was found to be similar in the various clones as seen in control Western blots (Figure 5a ). The cyclin E-associated kinase activity was unchanged in IkB-a overexpressing HeLa cells, whereas the activity of cyclin D1-associated kinases such as Cdk4 and Cdk6 was strongly elevated in these cells. This rather surprising result might be indicative for a cell cycle arrest at the late G1 stage before cyclin D1-dependent kinases drop in their activity (for review see Hunter and Pines, 1994) .
Inhibition of NF-kB aects the expression of p53 and p21 WAF and in¯uences the subcompartimentalization of c-Myc
The analysis of protein kinase activities was extended by comparing the tyrosine phosphorylation status between HeLa wt and IkB-a overexpressing HeLa cells. The cells were left untreated or stimulated for 2 h with PMA, a known inducer of protein kinase activity. Nuclear and cytoplasmic fractions of the cells were prepared and equal amounts of protein were separated by SDS ± PAGE and analysed by Western blotting. The tyrosine-phosphorylated proteins showed several differences, as detected with a monoclonal antibody ( Figure  5b ). The IkB-a overexpressing clones displayed a decreased basal phosphorylation of nuclear proteins with a molecular weight of 61 and 68 kDa and no tyrosine-phosphorylated protein bands of 65 and 28 kDa in the cytoplasmic fractions. PMA-treated IkB-a overexpressing cells showed induced nuclear phosphotyrosine proteins of 63 and 65 kDa molecular weight when compared to HeLa wt cells. These experiments show, that the inhibition of NF-kB by IkB-a overexpression does not only aect the activity of cyclin D1-associated kinases.
Since the activation of c-Myc contributes to the upregulation of the cyclin D1-associated kinases Cdk4 and Cdk6 (Steiner et al., 1995) , we compared the relative expression levels of c-Myc between HeLa wt and IkB-a overexpressing cells. Immuno¯uorescence analysis with a monoclonal antibody revealed a relatively even c-Myc staining in the nuclei of HeLa wt cells and a surprising condensation into some specles (which correspond to nucleoli) within the nucleus of IkB-a overexpressing clones (Figure 6a ). The total amount of c-Myc within the cells remained unchanged, as revealed by Western blotting ( Figure  6b ). After PMA-treatment for 2 h the c-Myc protein was predominantly localized in the cytoplasm of HeLa wt cells and strongly decreased in the IkB-a overexpressing cells (Figure 6c ). Since these results are rather unexpected and unusual, we repeated these experiments in HeLa cells that were transiently transfected with an IkB expression vector. The distribution of the c-Myc protein under various conditions was completely con®rmed by immunofluorescence analysis with monoclonal and polyclonal antibodies (data not shown). To determine whether the changes in the expression and localization of c-Myc might be due to a direct physical interaction with IkBa, the c-Myc, NF-kB p65 and IkB-a proteins were radioactively labeled by in vitro translation in the presence of 35 S-methionine. The labeled proteins were mixed in the indicated combinations ( Figure 6d ) and immunoprecipitated with a-IkB-a antibodies. The results con®rmed that the p65 protein coprecipitates with IkB-a, but there was no detectable interaction between the c-Myc protein and IkB-a under the conditions used.
To compare the expression levels of two other known regulators of the G1/S transition, p53 and p21 WAF , equal amounts of protein from total cell lysates were tested in Western blot experiments. IkB-a overexpressing cells showed elevated levels of p21 WAF ( Figure 7) . Signi®cantly lower levels of transcription factor p53 were found in the IkB-a overexpressing cells (Figure 8a ). Immuno¯uorescence studies con®rmed the decreased nuclear staining of the p53 protein in the IkB-a overexpressing cells, thus supporting the results obtained from the Western blots (Figure 8b ). Taken together, these experiments identify NF-kB as an important contributor to HeLa cell growth, directly or indirectly in¯uencing the relative abundance or subcellular localization of the cell cycle regulatory proteins p53, p21
WAF and c-Myc.
Discussion
In this study we inhibited NF-kB by stably overexpressing a transdominant negative form of IkB-a and analysed various parameters of the cell growth. The stable overexpression of IkB-a resulted in an almost complete inhibition of NF-kB. Only the faint residual NF-kB activity in IkB-a overexpressing cells might have allowed these cells to survive, because the complete inhibition of NF-kB in immature murine B-cells was previously shown to result in apoptosis (Wu et al., 1996b) . All of the 16 non-surviving cells lines displayed the changed, attened and elongated morphology typical for IkBa-overexpressing cells, suggesting that their death may have been a consequence of total NF-kB inhibition. Moreover, the association between elevated IkB-a levels, impaired NF-kB activation and slow growth rates in 18 HeLa cell clones strongly suggests a causal relationship between NF-kB activation and cell growth in HeLa cells. This study does not exclude the possibility of further mechan-B Figure 4 Cell cycle analysis of IkB-a overexpressing clones. (a) Kinetic analysis of the cell cycle. Vinblastine (1 mM) was added for the indicated periods and the DNA content was analysed as in Figure 3b . A representative experiment using IkB-a overexpressing clone 7 is shown. (b) Western blot analysis of cell cycle proteins. Equal amounts of total cellular proteins were separated by SDS ± PAGE and analysed by Western blotting for the abundance of the indicated proteins. The experiments were performed three times, typical results are displayed isms contributing to the growth-regulatory role of NF-kB. NF-kB may well directly or indirectly control the synthesis of an autocrine growth factor or proteins that are structurally important for cell division. Of note, the analysis of transgenic mice overexpressing IkB-a revealed evidence also for an inhibitory role of NF-kB during the growth of epidermal cells (Seitz et al., 1998) . Therefore, the role of NF-kB in cell growth or proliferation seems to be dependent on the tissue and cell type. Future studies must clarify a possible impact of IkB-a overexpression on the endogenously expressed papillomavirus proteins E6 and E7. However, since overexpression of a non-degradable IkB-a variant impaired the growth of Hodgkin's disease tumor cells lacking these viral oncogenes (Bargou et al., 1997), it seems that the growth inhibitory role of IkB-a is not restricted to HeLa cells.
The role of NF-kB in cell growth and malignant transformation
Previous studies correlated the proliferative state of a cell with the activation of NF-kB. Overexpression of the oncogenic forms of Ha-ras were associated with enhanced cell proliferation and activation of NF-kB (Finco et al., 1997) . Constitutive NF-kB activation was found to be associated with progression of breast cancer to hormone-independent growth (Nakshatri et al., 1997; Sovak et al., 1997) . Increased amounts of p65 were observed in human thyroid carcinoma cells (Visconti et al., 1997) and constitutive NF-kB activity was also identi®ed as a cause of uncontrolled growth of Hodgkin-Reed-Sternberg cells (Bargou et al., 1997) and in a bcr-abl-transformed cells (Reuther et al., 1998) . Conversely, the targeted deletion of the transactivating p65 subunit led to embryonic lethality at 15 ± 16 days A B Figure 5 Comparative analysis of protein kinase activities. (a) Activities of cyclin D1-and cyclin E-associated kinases. Extracts from sub-con¯uent growing HeLa wt and IkB-a overexpressing cells were assayed for the abundance of cyclin D1 and E by Western blotting (right) or for the activities of the associated kinases. After immunoprecipitation, the kinase activities were determined by incubation with the substrate proteins histon H1 or puri®ed GST-Rb protein in the presence of g-32 P-ATP. Representative autoradiograms from dried SDS gels are shown. (b) Multiple changes of tyrosine-phosphorylated proteins. HeLa wt and IkB-a overexpressing cells were left untreated or stimulated with PMA as indicated. Nuclear (N) and cytoplasmic (C) fractions were prepared and analysed by Western blotting for the occurrence of phosphotyrosines. The positions of prestained molecular mass markers are indicated. The experiments were independently performed two times with similar results of gestation and was accompanied by a massive degeneration of the liver , suggesting that certain cell types such as hepatocytes may be particularly important targets for the growth stimulatory eects of NF-kB. Complementary to the eects of NF-kB on the cell cycle progression, there is a body of evidence showing that NF-kB is also involved in oncogenesis. NF-kB/IkB proteins are members of a proto-oncogene family and the v-Rel oncoprotein is encoded by the avian Rev-T retrovirus. Viruses expressing v-rel can transform and immortalize hematopoietic cells such as B-cells, T-cells, dendritic and myeloid cells from birds in vitro (for review see Gilmore et al., 1996) .
Aberrations in NF-kB/IkB proteins are found in approximately 1 ± 10% of human B-and T-cell cancers (Fracchiolla et al., 1993) . The most commonly described rearrangements occur in the 3' portion of the NF-kB2 gene (Neri et al., 1991) . These C-terminal truncations lead to constitutively transactivating nuclear proteins (Chang et al., 1995) . Also transforming proteins from viruses are able to activate NF-kB, such as the Tax protein encoded by the human T-lymphotropic virus type I (HTLV-1), which can cause acute leukemia in CD4 + T cells (Paul et al., 1990) . Another example is the X protein from hepatitis B virus. It contributes to the development of liver cancer and is an activator of NF-kB (Lucito and Schneider, 1992) . This study reveals a mechanistic link between NF-kB inhibition and proliferative cell growth. We suggest that the inhibition of NF-kB or the overexpression of IkB-a might be used as therapeutic strategies for the treatment of proliferative disorders such as cancer.
The in¯uence of NF-kB on cell cycle checkpoints
The IkB-a overexpressing cell clones were characterized by a decreased percentage of cells in S phase and a reduced incorporation of BrdU. IkB-a overexpression led to a threefold slower cell growth, but the BrdU incorporation was only reduced about 50%. Therefore it may well be possible that the cells are not only accumulated in G1 (as seen by a variety of indicators) but also to a certain extent in other phases of the cell cycle. However, the multiple changes of known regulators of the G1/S phase described here provide strong support for a role of NF-kB in G1/S transition of HeLa cells. The stable overexpression of IkB-a resulted in the decreased expression of p53, a transcription factor that is known to regulate the progression through G1/S as well as G2/M (Agarwal et al., 1995) . How can cytoplasmatically localized NF-kB control transcriptional events during the cell cycle? The detailed analysis of the distribution of the DNA-binding subunits in many cell types and organs by immunostaining shows that individual cells within a tissue can contain a signi®cant amount of NF-kB in the nucleus. Such nuclear NF-kB proteins were also detected in exponentially growing HeLa cells (compare Figure 2a ). This amount of nuclear NF-kB should be sucient for the execution of the transcriptional eects that are necessary for cell cycle progression. Also the growth of B-lymphocytes, which contain a constitutively nuclear form of NF-kB, depends on the activity of NF-kB, as revealed by gene disruption experiments (Grumont et al., 1998) .
NF-kB is part of a regulatory network controlling G1/S transition
The inhibition of NF-kB resulted in a strong decrease in the p53 protein level in the nucleus. This might be a direct transcriptional eect of NFkB, because the p53 promoter contains a functional NF-kB binding site (Wu and Lozano, 1994) . Alternatively, it is possible that the overexpression of IkB-a results in a decreased stability of the p53 protein. Despite the decreased amount of p53 protein we found elevated p21 WAF protein levels, suggesting the use of an alternative activation cascade as already described for the regulation of p21 WAF expression in p53 knockout mice (Michieli et al., 1994) . One pathway is activated by DNA damage and involves transcriptional activation by p53, whereas the other p53-independent pathway is triggered in response to dierentiation signals and butyrate (Nakano et al., 1997) . Elevated levels of p21 WAF were shown to be sucient to retard the G1/S transition (Wu et al., 1996a) . Increased stability of p21 WAF was described as a mechanism of C/EBP mediated inhibition of cell proliferation (Timchenko et al., 1996) . c-Myc was previously shown to leave the nucleus when proliferation stops and to enter the nucleus prior to the S phase (Vriz et al., 1992) . The PMA- WAF expression. Equal amounts of total cellular proteins were compared in a Western blot for the abundance of the p21 WAF protein, which is indicated by an arrow. A representative experiment is shown induced cytoplasmic localization of the c-Myc protein described here seems to be independent from association with IkB-a, but may rely on the previously identi®ed interaction with microtubules and a-tubulin (Alexandrova et al., 1995) . In the IkB-a overexpressing cells the c-Myc protein was enriched in the nuclei. A nucleolar localization of c-Myc was already described earlier (Persson et al., 1986) , but the functional implications such as the recently suggested role for the synthesis of rRNA are unknown (Mateyak et al., 1997) . The c-Mycdependent mRNA expression and the reported induction of cyclin D-associated kinase activities (Steiner et al., 1995) were not tested here.
Surprisingly, the IkB-a overexpressing cells had elevated levels of cyclin D1-associated kinase activity despite the increased amount of p21 WAF . It might be possible that p21
WAF still counteracts the activities of the cyclin D1-associated Cdk4 and Cdk6 proteins. On the other hand it cannot be excluded that cyclin D1 is associated with further yet not de®ned kinases that are not regulated by p21
WAF . Alternatively, the elevated cyclin D1-associated kinase activity might counteract the IkB-a-induced growth arrest, thus enabling the stable clones to maintain a residual growth rate. Of note, all of these discussed models remain hypothetical and require additional experimental support in order to be proven. The activities of the cyclin D1-associated kinases Cdk4 and Cdk6 are increasing progressively, until the socalled restriction checkpoint in late G1 phase is reached (for review see Hunter and Pines, 1994) . This checkpoint is considered to be the`point of no return' within the G1/S transition and we suggest that IkB-a overexpression blocks G1/S transition near the restriction checkpoint. Taken together, NFkB/Rel transcription factors participate (directly or indirectly) in the control of a complex pattern of cell cycle regulators. The multiple changes in the phosphotyrosine pattern show that the inhibition of NF-kB leads to pleiotropic eects, so that more protein kinases in addition to Cdk4 and Cdk6 are aected in their activity.
Materials and methods

Eukaryotic cell culture and transfections
HeLa cells were grown at 378C in Dulbecco's modi®ed Eagle's Medium containing 1% penicillin/streptomycin and 10% fetal calf serum (all from GIBCO, Eggenstein, Germany) in a humidi®ed incubator. Approximately 5610 7 cells were transfected with the linearized vectors RcCMV or RcCMV-IkB-a S32/36A (Traenckner et al., 1995) . The plasmids were puri®ed on CsCl gradients and the HeLa cells were transfected with CaCl 2 as described (Schmitz et al., 1996) .
Cell extracts, electrophoretic mobility shift assays (EMSAs) and Western blotting HeLa cells (5610 5 ) were grown overnight on 10 cm dishes and stimulated for 20 min by PMA. Cells were washed twice with cold phosphate-buered saline and scraped o with a rubber policeman. After centrifugation for 3 min with 3000 r.p.m. the total cellular proteins were extracted from the pellet by resuspension in TOTEX buer (20 mM HEPES/ KOH pH 7.9, 0.35 M NaCl, 20% (v/v) glycerol, 1% (v/v) NP-40, 1 mM MgCl 2 , 0.5 mM EDTA, 0.1 mM EGTA, 1 mM PMSF) and incubation on ice for 30 min. The tubes were carefully vortexed every 10 min and the cell debris was pelleted upon centrifugation with 14 000 r.p.m. at 48C for 10 min. Equal amounts of protein contained in the supernatant were tested for DNA binding activity. The extracts were incubated with 2 mg poly (dI-dC), 2 mg BSA and 10 000 c.p.m. of a 32 P-labeled oligonucleotide on ice in 56 binding buer (20% (w/v) Ficoll 400, 100 mM HEPES/KOH pH 7.9, 1 mM DTT and 300 mM KCl) in a ®nal volume of 20 ml. The oligonucleotides used were 5'-AGTTGAG-GGGACTTTCCCAGGC-3' and 3'-TCAACTCCCCT-GAAAGGGTC-CG-5' (the NF-kB binding site is underlined). The free and the protein-bound oligonucleotides were separated by electrophoresis on a native 4% polyacrylamide gel as described (Hehner et al., 1998) . After electrophoresis the gel was dried and exposed to an X-ray ®lm (Amersham Hyper®lm).
For Western blotting the proteins were transferred from the SDS gel onto a polyvinylidene di¯uoride membrane (Millipore, Bedford, MA, USA) in a semi-dry-blot apparatus (Bio-Rad, Munich, Germany) according to the instructions of the manufacturers. The detection of proteins was performed by ®rst washing the membrane twice in TBST (25 mM Tris/ HCl pH 7.4, 137 mM NaCl, 5 mM KCl, 0.7 mM CaCl 2 , 0.1 mM MgCl 2 , 0.05% Tween20) and a subsequent incubation in TBST containing 5% non-fat dry milk powder for 1 h. The membrane was then incubated in a small volume of TBST, containing dilutions between 1 : 500 and 1 : 2000 of the respective antibodies. The antibodies directed against IkB-a, cyclin D1 (R-124), cyclin E, c-Myc (9E10) were from Santa Cruz Inc. (Santa Cruz, CA, USA), the a-phosphotyrosine (4G10) antibody was from Upstate Biotech (Lake Placid, NY, USA). The a-p21 WAF (EA10), a-cyclin D3 (18B6-10), cyclin B1 (CC03-S) and a-Cdk5 (DC17) and a-p53 (DO-1) antibodies were from Calbiochem (Bad Soden, Germany). After a 3 h incubation at room temperature, the membrane was repeatedly washed in TBST and incubated for another hour in TBST containing a 1 : 3000 dilution of the second antibody coupled to horseradish peroxidase (Bio-Rad, Munich, Germany). After extensive washing the bound antibodies were detected using the ECL-system (Amersham Lifescience, Braunschweig, Germany), according to manufacturer's instructions.
Immuno¯uorescence
HeLa cells were ®xed for 5 min in 96% ethanol and for 2 min in 3.7% formaldehyde. Immuno¯uorescence stainings were done as previously described . The primary antibody a-p65 (12H11) was from Boehringer Manheim (Mannheim, Germany). They were routinely diluted 1 : 50 and detected with a secondary Cy3-coupled antibody in a 1 : 100 dilution.
FACS analysis
For the analysis of cell cycle parameters the cells were trypsinized and ®xed with 70% (v/v) ethanol. After centrifugation of cells, the pellet was resuspended in staining solution (PBS containing 1 mg glucose, 50 mg propidium iodide and 100 Kunitz units RNaseA). The DNA content was analysed in ā ow cytometer after incubation for 60 min at 378C as described (Coligan et al., 1997) . The DNA was analysed by¯ow cytometry using a FACScan analyser with CellQuest software (Becton-Dickinson, Heidelberg, Germany).
BrdU incorporation
Pulse labeling with BrdU was performed with the BrdU labeling and detection kit 1 (Boehringer Mannheim, Mann-heim, Germany) according to the manufacturer's instructions. Statistical analysis was done using ANOVA. A star marks a statistically signi®cant dierence at P50.01 of BrdU incorporation measured in HeLa wt and in the respective IkB-a overexpressing cell lines (Schee's post hoc test).
Kinase assays
The activity of the kinases associated to cyclins D1 and E was assessed essentially as described (Dulic et al., 1992) . Brie¯y, approximately 5610 6 cells were lysed in lysis buer (50 mM HEPES/KOH pH 7.5, 0.15 M NaCl, 10% (v/v) glycerol, 0.1% (v/v) Tween20, 1 mM EDTA, 2.5 mM EGTA, 1 mM DTT, 10 mM b-glycerophosphate, 1 mM NaF, 1 mM PMSF, 100 mM vanadate, 10 mg/ml leupeptin, 2 mg/ml aprotinin) and incubated on ice for 30 min. The tubes were carefully vortexed every 10 min and the cell debris was pelleted upon centrifugation with 14 000 r.p.m. at 48C for 10 min. The supernatant was incubated with 4 ml of aCyc D1 or a-cyc E antibodies and 40 ml of protein A/G sepharose beads. The precipitates were washed four times in lysis buer. The kinase reaction was performed in kinase buer (50 mM HEPES/KOH pH 7.5, 10 mM MgCl 2 , 2.5 mM EGTA, 10 mM b-glycerophosphate, 1 mM NaF, 100 mM vanadate, 1 mM DTT) in the presence of 2 mg of substrate protein. BSA was from Boehringer Mannheim (Mannheim, Germany), the glutathione-S-transferase (GST)-Rb protein was expressed and puri®ed from E. coli according to standard protocols.
Coprecipitation experiments
The NF-kB p65, c-Myc and IkB-a proteins were labeled with 35 S-methionine (Amersham Lifescience, Braunschweig, Germany) using the coupled TnT in vitro transcription/ translation system from rabbit reticulocytes (Promega Inc., Madison, WI, USA). Equal amounts of 35 S-labeled proteins were incubated in binding buer (BB) consisting of 12 mM HEPES/KOH pH 8, 12% glycerol, 100 mM NaCl, 5 mM KCl, 5 mM MgCl 2 , 1 mM b-mercaptoethanol, 1 mM PMSF, 10 mM ZnCl 2 and 1 mM spermidine. Binding reactions were allowed at room temperature for 20 min. Subsequently 2 ml of a polyclonal rabbit antibody directed against the human IkB-a was added together with 40 ml of protein A/G-coupled sepharose beads. After another incubation for 3 h at 48C on a rotating wheel the beads were washed several times in binding buer. The bound proteins were eluted by boiling the sepharose beads in 16SDS sample buer and separated by electrophoresis on a 12% polyacrylamide gel. The gels were subsequently dried and exposed to an X-ray ®lm at 7808C.
Abbreviations
BrdU, bromodeoxyuridine; EMSA, electrophoretic mobility shift assay; GST, glutathione-S-transferase; IKK, IkBa kinase; IL-1, interleukin-1; LPS, lipopolysaccharide; TNF-a, tumor necrosis factor a.
